Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic drivers of disease.
The system predicts how DNA mutations disrupt gene regulation across different tissues.
AlphaGenome can analyse up to one million DNA letters simultaneously.
Most inherited diseases link to regulatory mutations rather than protein-coding genes.
Researchers trained the model on large human and mouse genetics databases.
Scientists say it could accelerate cancer research and enable targeted gene therapies.
Experts describe AlphaGenome as a major step toward understanding the non-coding genome.
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
